Major Recent Trials in Cardiovascular Diseases

References

• . Ridker PM, Danielson E, Fonseca FA,; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–2207
   PubMed Web of Science ®Google Scholar
• . Kastelein JJ, Akdim F, Stroes ES,; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008;358(14):1431–1443
   PubMed Web of Science ®Google Scholar
• . Jamerson K, Weber MA, Bakris GL,; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417–2428
   PubMed Web of Science ®Google Scholar
• . , Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) InvestigatorsYusuf S, Teo K, Anderson C,. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008;372(9644):1174–1183
   PubMed Web of Science ®Google Scholar
• . UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853
   PubMed Web of Science ®Google Scholar
• . Tavazzi L, Maggioni AP, Marchioli R,. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1223–1230
   PubMed Web of Science ®Google Scholar
• . Tavazzi L, Maggioni AP, Marchioli R,. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1231–1239
   PubMed Web of Science ®Google Scholar
• . Gheorghiade M, Blair JEA, Filippatos GS,; HORIZON-HF Investigators. Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure. J Am Coll Cardiol. 2008;51(23):2276–2285
   PubMed Web of Science ®Google Scholar
• . O'Connor C. HF-ACTION-Heart Failure—A randomized controlled trial investigating outcomes of exercise training. Presented at: American Heart Association Scientific Sessions; November 11, 2008; New Orleans, LA
   Google Scholar
• . Frustaci A. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy. Presented at: European Society of Cardiology Congress; September 3, 2008; Munich, Germany
   Google Scholar
• . Greenberg B, Czerska B, Delgado RM,; MOMENTUM Investigators and Coordinators. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM). Circulation. 2008;118(12):1241–1249
   PubMed Web of Science ®Google Scholar
• . Dorian P, Al-Khalidi HR, Hohnloser SH,; Shock Inhibition Evaluation with Azimilide Investigators. Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trial. Shock Inhibition Evaluation with Azimilide Investigators. J Am Coll Cardiol. 2008;52(13):1076–1083
   PubMedGoogle Scholar
• . Hohnloser SH. A placebo-controlled, double-blind, parallel arm trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/ atrial flutter (AF/AFL). Presented at: Heart Rhythm Society Scientific Sessions; May 15, 2008; San Francisco, CA
   Google Scholar
• . Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52(23):1834–1843
   PubMed Web of Science ®Google Scholar
• . Connolly SJ. ATHENA: The effect of dronedarone on cardiovascular outcomes and stroke in patients with atrial fibrillation. Presented at: European Society of Cardiology Congress; September 3, 2008; Munich, Germany
   Google Scholar
• . Di Tullio MR, Homma S, Jin Z, Sacco RL. Aortic atherosclerosis, hypercoagulability, and stroke the APRIS (Aortic Plaque and Risk of Ischemic Stroke) study. J Am Coll Cardiol. 2008;52(10):855–861
   PubMed Web of Science ®Google Scholar
• . Kastrati A, Neumann FJ, Mehilli J,; ISAR-REACT 3 Trial Investigators. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med. 2008;359(7):688–696
   PubMed Web of Science ®Google Scholar
• . Alexander J. Safety of the factor Xa inhibitor, apixaban, in combination with antiplatelet therapy after acute coronary syndrome: results of the APPRAISE-I dose guiding trial. Presented at: European Society of Cardiology Congress; September 2, 2008; Munich, Germany
   Google Scholar
• . Kapur A. Coronary Artery Revascularization in Diabetes: The CARDia trial. Presented at: European Society of Cardiology Congress; September 1, 2008; Munich, Germany
   Google Scholar
• . Atar D. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 on ischemia reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention (the FIRE trial). J Am Coll Cardiol. Published online January 28, 2009
   Google Scholar
• . Tendera M. Myocardial regeneration by intracoronary infusion in AMI (REGENT) randomized trial. Presented at: European Society of Cardiology Congress; September 2, 2008; Munich, Germany
   Google Scholar
• . Dangas G. MATRIX registry study. Presented at: American College of Cardiology Scientific Sessions/i2 Summit-SCAI Annual Meeting; March 31, 2008; Chicago, IL
   Google Scholar